-
Judge Gilstrap finds Verizon reasonably expected not to get sued by Headwater (in which it invested), tosses $175M jury verdict
Read more: Judge Gilstrap finds Verizon reasonably expected not to get sued by Headwater (in which it invested), tosses $175M jury verdictJudge Gilstrap’s passion for patent law is evidenced by how he uses “to teach away” in a context in which it is highly uncommon terminology.
-
CureVac sues Moderna in Delaware over Spikevax patents, seeking treble damages but no injunction
Read more: CureVac sues Moderna in Delaware over Spikevax patents, seeking treble damages but no injunctionCureVac sues Moderna for treble damages but not an injunction over 10 patents related to Spikevax. The case adds to broader post-COVID mRNA patent battles.
-
Disney faces clear and present danger of UPC 11-country HEVC patent injunction in InterDigital case after May 5 & 6 hearing: court document
Read more: Disney faces clear and present danger of UPC 11-country HEVC patent injunction in InterDigital case after May 5 & 6 hearing: court documentThe UPC Mannheim LD appears unconvinced of Disney’s technical defenses, and even if the court deemed Disney entitled to a FRAND license, an injunction would probably issue.
-
IP Bridge’s Geely injunction stayed in Brazil; GWM proceedings show ongoing enforcement
Read more: IP Bridge’s Geely injunction stayed in Brazil; GWM proceedings show ongoing enforcementPreliminary injunction-related developments in Brazil’s SEP disputes have been prematurely characterized as a shift against strong enforcement. A temporary appellate measure is not a final reversal, and parallel proceedings against GWM are ongoing.
-
ECJ Advocate General says excipient label is binding for SPC purposes: Halozyme v. Czech IPO
Read more: ECJ Advocate General says excipient label is binding for SPC purposes: Halozyme v. Czech IPOAG Emiliou says a substance in a MA that is called an excipient may not be considered an active ingredient for SPC purposes, which would invalidate grants in eight EU member states.
-
UPC CD Paris says expired BASF patent still open to attack, makes own determination of technical problem
Read more: UPC CD Paris says expired BASF patent still open to attack, makes own determination of technical problemThe UPC’s CD Paris dismissed Huntsman’s revocation action against BASF’s expired EP1516720, confirming that expired patents may still be challenged where past-damage exposure remains live.
-
Toyota acquires patents from LG as it looks to expand its licensor role, including in Avanci pools
Read more: Toyota acquires patents from LG as it looks to expand its licensor role, including in Avanci poolsThe Japanese automaker had previously acquired mobile-related patents from China’s OPPO.
-
Quantificare v. Canfield Scientific: Dusseldorf LD finds infringement across four UPC states, rejects invalidity counterclaim
Read more: Quantificare v. Canfield Scientific: Dusseldorf LD finds infringement across four UPC states, rejects invalidity counterclaimThe UPC’s Dusseldorf LD ruled that a confirmed infringing act in one contracting member state is enough to support a pan-UPCland injunction, even where the only provable act is in a country the patent holder deliberately carved out of its claim.
Follow Us
Latest Articles
- Think twice before filing in the UPC if you foresee a private-prior-use defense under German law: further Fujifilm v. Kodak analysis
- Incyte acquires bleeding-disorder biotech Vega Therapeutics as Jakafi patent cliff looms
- UPC Roundup (1 week): security decisions (no SME bonus, parent company doesn’t count); two failed infringement lawsuits; more
- BREAKING: Avanci signed up four Chinese automakers as licensees between early April and now; 11 Chinese licensees in total, 17 contracts
- Neither does the UPC need Spain and Poland — nor vice versa; but Ireland is an unfortunate outlier among non-members